Evidence map›Paper›PMID 27322546›Full record

ArticleNature genetics2016

Functional characterization of somatic mutations in cancer using network-based inference of protein activity.

Mariano J Alvarez, Yao Shen, Federico M Giorgi, Alexander Lachmann, B Belinda Ding, B Hilda Ye, Andrea Califano

Open access · bronzeAbstract read
In one paragraph

Article in Nature genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 592 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
592citing papers in PubMed, 2 pooled it
29.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

592 citing papers in PubMed, 2 syntheses or guidelines pooled it, 1,038 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

532 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Mariano J AlvarezDepartment of Systems Biology, Columbia University, New York, New York, USA.
Yao ShenDepartment of Systems Biology, Columbia University, New York, New York, USA.
Federico M GiorgiDepartment of Systems Biology, Columbia University, New York, New York, USA.
Alexander LachmannDepartment of Systems Biology, Columbia University, New York, New York, USA.
B Belinda DingDepartment of Cell Biology, Albert Einstein College of Medicine, New York, New York, USA.
B Hilda YeDepartment of Cell Biology, Albert Einstein College of Medicine, New York, New York, USA.
Andrea CalifanoDepartment of Systems Biology, Columbia University, New York, New York, USA.
Albert Einstein College of Medicine · USColumbia University · USDarwinHealth (United States) · USCancer Genetics (United States) · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
Nation Center: Multi-Scale Study- Cellular Networks(RMI)U54CA121852 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA · 2005 to 2015
$37.4M
Predicting Cancer Cell Response to Endogenous and Exogenous Perturbations at the Single Cell LevelR35CA197745 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ANDREA CALIFANO · 2015 to 2026
$11.5M
Systems Biology of Tumor Progression and Drug ResistanceU01CA168426 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA · 2012 to 2016
$6.5M
ROLE OF THE BCL 6 PROTO ONCOGENE IN B CELL LYMPHOMASR01CA085573 · NCI · YESHIVA UNIVERSITY · PI YE, BIHUI HILDA · 2000 to 2010
$3.4M
Profiling Signatures of synergistic Chemical Perturbations in Diverse Cellular CU01CA164184 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA · 2011 to 2013
$2.1M
High-performance compute cluster for biomedical computingS10OD012351 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA · 2012 to 2012
$2.0M
Storage System for High Performance ComputingS10OD021764 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA · 2016 to 2016
$600k
NCI NIH HHS P30 CA013330NCI NIH HHS R01 CA085573NCI NIH HHS R35 CA197745NCI NIH HHS U01 CA164184NCI NIH HHS U01 CA168426NCI NIH HHS U54 CA121852NIH HHS S10 OD012351NIH HHS S10 OD021764
6 · The paper itself

Abstract

Identifying the multiple dysregulated oncoproteins that contribute to tumorigenesis in a given patient is crucial for developing personalized treatment plans. However, accurate inference of aberrant protein activity in biological samples is still challenging as genetic alterations are only partially predictive and direct measurements of protein activity are generally not feasible. To address this problem we introduce and experimentally validate a new algorithm, virtual inference of protein activity by enriched regulon analysis (VIPER), for accurate assessment of protein activity from gene expression data. We used VIPER to evaluate the functional relevance of genetic alterations in regulatory proteins across all samples in The Cancer Genome Atlas (TCGA). In addition to accurately infer aberrant protein activity induced by established mutations, we also identified a fraction of tumors with aberrant activity of druggable oncoproteins despite a lack of mutations, and vice versa. In vitro assays confirmed that VIPER-inferred protein activity outperformed mutational analysis in predicting sensitivity to targeted inhibitors.

Indexed as

AlgorithmsAntineoplastic AgentsComputational BiologyDatabases, PharmaceuticalDatabases, ProteinGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansMutationNeoplasm ProteinsNeoplasmsProtein Interaction MapsProtein Structure, TertiaryAntineoplastic AgentsNeoplasm Proteins

Identifiers

PMID27322546
PMCPMC5040167
OpenAlexW2472255748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.